Never-smoker patients with SCLC are reported to have different molecular alterations, the most common being EGFR, MET (mesenchymal epithelial transition), and SMD2 (mothers against decapentaplegic homolog 2) [4,5,6]. This evidence concerns the gene EGFR and small cell lung carcinoma.